Apocynin
(Synonyms: 香草乙酮; Acetovanillone) 目录号 : GC16237
Apocynin是一种天然存在的苯乙酮类化合物，可作为NADPH氧化酶复合物的强效抑制剂，IC50值为10μM。
Cas No.:498-02-2
Sample solution is provided at 25 µL, 10mM.
Apocynin, a naturally occurring acetophenone, is a potent inhibitor of the complex NADPH-oxidase with an IC50 value of 10μM[1]. Apocynin prevents translocation of p47phox subunit to the plasma membrane[2]. Apocynin can inhibit the generation of eNOS-dependent superoxide in diabetic cardiomyopathy, reduce the activation of NLRP3 and TGFβ/Smad signaling in diabetic nephropathy, and serve as a model compound for developing new therapeutic drugs for cardiovascular diseases[3].
In vitro, Apocynin treatment (300µM; 6h) increased the accumulation of nitrite in the extracellular culture medium of N11 mouse glial cells, and enhanced the activity of nitric oxide synthase (NOS) in the cell lysates[4]. Treatment of rat vascular smooth muscle cells with 100μM Apocynin for 15 minutes significantly inhibited the phosphorylation of Akt and extracellular signal-regulated kinase 1/2, and weakened the activation of p38 mitogen-activated protein kinase and Akt and extracellular signal-regulated kinase 1/2 induced by reactive oxygen species (ROS), as well as the production of superoxide anions[5].
In vivo, Apocynin treatment via intraperitoneal injection of 10mg/kg/day for 4 consecutive days can alleviate the morphological and histological changes in the lungs of rats induced by lipopolysaccharide (LPS), reduce pulmonary edema, lower pulmonary permeability, and decrease the MPO activity induced by LPS in the bronchoalveolar fluid and lung homogenate of rats, as well as TNF-α and IL-1β in the plasma[6]. Intravenous injection of 2.5mg/kg of Apocynin for 30 minutes before experimental stroke can improve neurological function, reduce infarct volume, and decrease the incidence of cerebral hemorrhage in the mouse model[7]. In SAMP6 mice, after 3 months of treatment with Apocynin via intraperitoneal injection (0.1mg/kg/day), both bone mineral density and total bone mass increased, and the activity of osteoblasts significantly enhanced in shin bones of mice[8].
References:
[1] Stefanska J, Pawliczak R. Apocynin: molecular aptitudes[J]. Mediators of inflammation, 2008, 2008(1): 106507.
[2] Savla S R, Laddha A P, Kulkarni Y A. Pharmacology of apocynin: a natural acetophenone[J]. Drug metabolism reviews, 2021, 53(4): 542-562.
[3] Bhatia A, Thakur S, Kohal R, et al. A comprehensive update on phytochemistry and medicinal developments of apocynin[J]. Fitoterapia, 2025: 106558.
[4] Riganti C, Costamagna C, Doublier S, et al. The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress[J]. Toxicology and applied pharmacology, 2008, 228(3): 277-285.
[5] Heumüller S, Wind S, Barbosa-Sicard E, et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant[J]. Hypertension, 2008, 51(2): 211-217.
[6] Kouki A, Ferjani W, Ghanem-Boughanmi N, et al. The NADPH oxidase inhibitors apocynin and diphenyleneiodonium protect rats from LPS-induced pulmonary inflammation[J]. Antioxidants, 2023, 12(3): 770.
[7] Tang X N, Cairns B, Cairns N, et al. Apocynin improves outcome in experimental stroke with a narrow dose range[J]. Neuroscience, 2008, 154(2): 556-562.
[8] Sun J, Ming L, Shang F, et al. Apocynin suppression of NADPH oxidase reverses the aging process in mesenchymal stem cells to promote osteogenesis and increase bone mass[J]. Scientific Reports, 2015, 5(1): 18572.
Apocynin是一种天然存在的苯乙酮类化合物，可作为NADPH氧化酶复合物的强效抑制剂，IC50值为10μM[1]。Apocynin可以阻止p47phox亚基向质膜转位[2]。Apocynin能抑制糖尿病心肌病中eNOS依赖性超氧化物的产生，降低糖尿病肾病中NLRP3和TGFβ/Smad信号通路的激活，是心血管疾病新药开发的模型化合物[3]。
在体外，300μM浓度的Apocynin处理N11小鼠胶质细胞6小时后，可增加细胞培养液中亚硝酸盐的积累，并提升细胞裂解物中一氧化氮合酶（NOS）活性[4]。100μM浓度的Apocynin处理大鼠血管平滑肌细胞15分钟，能显著抑制Akt和细胞外信号调节激酶1/2的磷酸化，减弱活性氧（ROS）诱导的p38丝裂原活化蛋白激酶、Akt及ERK1/2激活，同时减少超氧阴离子生成[5]。
在体内，大鼠连续4天腹腔注射10mg/kg/day剂量的Apocynin，可缓解脂多糖(LPS)诱导的肺组织形态学改变，减轻肺水肿、降低肺通透性，并减少支气管肺泡灌洗液和肺匀浆中MPO活性及血浆TNF-α、IL-1β水平[6]。实验性脑卒中前30分钟静脉注射2.5mg/kg剂量的Apocynin，能改善小鼠神经功能、缩小梗死体积并降低脑出血发生率[7]。在 SAMP6 小鼠中，通过腹腔注射Apocynin（0.1mg/kg/day）治疗3个月后，小鼠胫骨的骨物质密度和总骨量均有所增加，成骨细胞的活性也显著增强[8]。
| Cell experiment [1]: | |
Cell lines | The N11 mouse glial cell |
Preparation Method | The N11 mouse glial cells were cultured in a 35-mm diameter (used for determining nitrite, hydrogen peroxide and enzyme activities) petri dish until confluence. The culture medium was Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum. Then, the cells were incubated for 6 hours with Apocynin (10, 30, 60, 100, 300, 600, 1200µM). After incubation, 0.15ml of cell culture medium was added to 0.15ml of Griess reagent in a 96-well plate and incubated at 37°C in the dark for 10 minutes. The absorbance at 540nm was measured using a microplate reader. A blank was prepared without cells and the absorbance from the samples was subtracted from it. A calibration curve was established using nitrite as the standard. The nitrite concentration was expressed as nmol nitrite/h/mg cellular protein. The confluent cells grown in the 35-mm diameter petri dish were separated using trypsin/EDTA, washed with PBS, and resuspended in 0.3ml of Hepes/EDTA/DTT buffer (20mM Hepes, 0.5mM EDTA, 1mM DTT, pH 7.2). Two 10-second ultrasonic treatments were performed on the sample on ice. The NOS activity of 100µg of cell lysate was determined using a nitric oxide synthase ultrasensitive colorimetric assay kit. This method uses the NADPH cycling system to enable NOS to catalyze the production of NO at a constant level for several hours. The stable NO degradation product nitrite accumulated during this period was determined using Griess reagent. |
Reaction Conditions | 10, 30, 60, 100, 300, 600, 1200µM; 6h |
Applications | Apocynin significantly enhanced the accumulation of nitrite and promoted NOS activity in N11 mouse glial cells. |
| Animal experiment [2]: | |
Animal models | Male Wistar rat |
Preparation Method | Male Wistar rats, weighing 213 ± 15g, were randomly divided into four groups, with five rats in each group. All the rats were raised under controlled conditions throughout the experiment. The rats had free access to water. The environmental conditions included a temperature of (22 ± 1℃), humidity of (65-70%), and a 12:12 hour light-dark cycle. Two groups (the control group and the LPS group) were intraperitoneally injected with dimethyl sulfoxide (DMSO) every day for two consecutive days. The control group was instilled with PBS, while the LPS group was instilled with LPS (1.5mg/mL). The AP group and (AP + LPS) group were intraperitoneally injected with Apocynin dissolved in DMSO (10mg/kg) every day, followed by instillation with PBS. The (AP + LPS) group was treatment with Apocynin (10mg/kg; i.p) + LPS (1.5mg/mL). The entire experiment lasted for 4 days. At the end of the experiment, the rats were decapitated. The plasma and organs were carefully collected. The lung tissue was fixed in 10% formalin-PBS solution overnight, dehydrated in gradient ethanol solution, and embedded in paraffin. The tissue specimens were cut into 5µm thick sections, stained with hematoxylin-eosin (H&E), and examined under an optical microscope. |
Dosage form | 10mg/kg/day for 4 days; i.p. |
Applications | Apocynin treatment significantly alleviated the pulmonary morphological and histological changes induced by LPS, as well as reduced pulmonary edema in rats. |
References: | |
| Cas No. | 498-02-2 | SDF | |
| 别名 | 香草乙酮; Acetovanillone | ||
| Canonical SMILES | OC1=CC=C(C(C)=O)C=C1OC | ||
| 分子式 | C9H10O3 | 分子量 | 166.17 |
| 溶解度 | ≥ 8.25mg/mL in DMSO | 储存条件 | Store at RT |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 6.0179 mL | 30.0897 mL | 60.1793 mL |
| 5 mM | 1.2036 mL | 6.0179 mL | 12.0359 mL |
| 10 mM | 0.6018 mL | 3.009 mL | 6.0179 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet